Skip to main content

Effort To Launch A “Negotiation Class” For Opioid MDL

Effort To Launch A “Negotiation Class” For Opioid MDL

Effort To Launch A “Negotiation Class” For Opioid MDL

Introduction

On Friday, June 14th, the plaintiff lawyers on behalf of the local governments proposed to create a "Negotiation Class" of cities and counties to seek a global settlement with drug companies accused of the opioid crisis.

According to the motion for class certification, nearly 40 local governments including the cities of Atlanta, Chicago, and San Francisco have moved to establish a deal with drug manufacturers, distributors, and pharmacies accused of the opioid crisis. Following the proposal, the county and municipal entities in the U.S. can participate collectively, through their representatives, in any settlement discussions that the defendants choose to conduct on a classwide basis and to vote to accept or reject any proposed resolution. The system would require approval by at least 75% supermajorities of litigating and non-litigating cities and counties, 75% of the population and 75% of the allocations to the cities and counties. It has also outlined a three-part formula for allocating settlement dollars. The three factors would include the extent of opioid sales in a given area, an area’s overdose deaths, and opioid-addicted residents.

U.S. District Judge Dan Polster is presiding over more than 1,900 lawsuits filed under MDL No. 2804 (In Re: National Prescription Opiate Litigation) by U.S. cities and counties of which more than 1,600 cases are filed largely by local governments, Native American tribes, and hospitals.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!